Emergent Biosolutions Inc. Capex/Depreciation

Capex/Depreciation of EBS for past 10 years: annual, quarterly and twelve month trailing (TTM) including Capex/Depreciation growth rates and interactive chart.


Highlights and Quick Summary

  • Capex/Depreciation for the quarter ending June 30, 2023 was -0.3 (a -29.51% decrease compared to previous quarter)
  • Year-over-year quarterly Capex/Depreciation decreased by -64.2%
  • Annual Capex/Depreciation for 2022 was -0.93 (a -46.94% decrease from previous year)
  • Annual Capex/Depreciation for 2021 was -1.76 (a 47.23% increase from previous year)
  • Annual Capex/Depreciation for 2020 was -1.19 (a 56.34% increase from previous year)
  • Twelve month Capex/Depreciation ending June 30, 2023 was -0.54 (a -17.85% decrease compared to previous quarter)
  • Twelve month trailing Capex/Depreciation decreased by -45.53% year-over-year
Trailing Capex/Depreciation for the last four month:
30 Jun '23 31 Mar '23 31 Dec '22 30 Sep '22
-0.54 -0.65 -0.79 -0.99
Visit stockrow.com/EBS for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Capex/Depreciation of Emergent Biosolutions Inc.

Most recent Capex/Depreciationof EBS including historical data for past 10 years.

Interactive Chart of Capex/Depreciation of Emergent Biosolutions Inc.

Emergent Biosolutions Inc. Capex/Depreciation for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2023 -0.3 -0.42
2022 -1.24 -0.84 -0.71 -1.01 -0.93
2021 -1.55 -1.63 -1.96 -1.89 -1.76
2020 -1.2 -1.54 -1.19 -0.84 -1.19
2019 -1.26 -0.54 -0.48 -0.78 -0.76
2018 -0.8 -2.1 -0.89 -0.94 -1.1
2017 -0.86 -1.3 -0.94 -2.0 -1.24
2016 -1.99 -1.64 -2.36 -2.06 -1.99
2015 -1.18 -1.63 -1.21 -1.06 -1.27
2014 -1.97 -0.58 -0.57 -0.67 -0.95
2013 -1.4 -3.92 -1.53 -1.84 -2.22
2012 -3.67 -3.62 -3.76

Business Profile of Emergent Biosolutions Inc.

Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic